Indeed, in various cancer types (e.g., bladder, non-small cell lung, ovarian, prostate cancer, and clear cell renal cell carcinoma) [62,63], RAB25 overexpression has been associated with shorter overall survival. The gene discussed is RAB25; the disease is Familial prostate cancer.